Skip to main content
Top
Published in: BMC Neurology 1/2020

Open Access 01-12-2020 | Verapamil | Case report

Moyamoya-like vasculopathy associated to MYH9-related thrombocytopenia manifested by multiple cerebral ischemic lesions: a case report

Authors: Athena Cristina Ribigan, Raluca Stefania Badea, Alida Ciocan, Dana Stefan, Bogdan Casaru, Patricia Ioan, Florina Antochi, Ovidiu Băjenaru

Published in: BMC Neurology | Issue 1/2020

Login to get access

Abstract

Background

Moyamoya-like vasculopathy (MMV) and myosin heavy chain 9-related platelet disorders (MYH9-RPDs) or macrothrombocitopenias are rare syndromes. Their association is even more infrequent.

Case presentation

A 29-year-old female with history of MYH9-RPD, presented to our department for episodes suggesting transient ischemic attacks. Based on the imaging studies that revealed multiple ischemic lesions and stenoses of both distal internal carotid arteries and the arteries of the circle of Willis, the diagnosis of MMV was established. The treatment with Verapamil was initiated, leading to symptom remission. Two months later, the patient presented one episode of dysarthria, followed by involuntary movements of the right upper limb, few days later. Long-term electroencephalogram monitoring depicted epileptiform abnormalities. Resolution of symptoms was obtained after increasing the dose of Verapamil, and initiating Levetiracetam.

Conclusions

This is an interesting case of a patient with two rare pathologies, who presented with cerebral ischemic strokes. To our knowledge there are few cases described in the literature presenting with cerebral hemorrhagic events but none of them with multiple cerebral ischemic lesions. As these cases are very rare, it is important to gather evidence regarding the best approach and treatment strategy.
Literature
1.
go back to reference Kraemer M, Heienbrok W, Berlit P. Moyamoya disease in Europeans. Stroke. 2008;39(12):3193–200.CrossRef Kraemer M, Heienbrok W, Berlit P. Moyamoya disease in Europeans. Stroke. 2008;39(12):3193–200.CrossRef
2.
go back to reference Phi JH, Wang KC, Lee JY, Kim SK. Moyamoya syndrome: a window of Moyamoya disease. J Korean Neurosurg Soc. 2015;57(6):408–14.CrossRef Phi JH, Wang KC, Lee JY, Kim SK. Moyamoya syndrome: a window of Moyamoya disease. J Korean Neurosurg Soc. 2015;57(6):408–14.CrossRef
3.
go back to reference Althaus K, Greinacher A. MYH9-related platelet disorders. Semin Thromb Hemost. 2009;35(2):189–203.CrossRef Althaus K, Greinacher A. MYH9-related platelet disorders. Semin Thromb Hemost. 2009;35(2):189–203.CrossRef
4.
go back to reference Guey S, Tournier-Lasserve E, Herve D, Kossorotoff M. Moyamoya disease and syndromes: from genetics to clinical management. Appl Clin Genet. 2015;8:49–68.PubMedPubMedCentral Guey S, Tournier-Lasserve E, Herve D, Kossorotoff M. Moyamoya disease and syndromes: from genetics to clinical management. Appl Clin Genet. 2015;8:49–68.PubMedPubMedCentral
5.
go back to reference Lazzaro MA, Cochran EJ, Lopes DK, Prabhakaran S. Moyamoya syndrome in an adult with essential thrombocythemia. Neurol Int. 2011;3(1):e3.CrossRef Lazzaro MA, Cochran EJ, Lopes DK, Prabhakaran S. Moyamoya syndrome in an adult with essential thrombocythemia. Neurol Int. 2011;3(1):e3.CrossRef
6.
go back to reference Hayashi T, Akioka N, Kashiwazaki D, Kuwayama N, Kuroda S. Ischemic stroke in pediatric moyamoya disease associated with immune thrombocytopenia--a case report. Childs Nerv Syst. 2015;31(6):991–6.CrossRef Hayashi T, Akioka N, Kashiwazaki D, Kuwayama N, Kuroda S. Ischemic stroke in pediatric moyamoya disease associated with immune thrombocytopenia--a case report. Childs Nerv Syst. 2015;31(6):991–6.CrossRef
7.
go back to reference Bejot Y, Barnay JL, Chavent A, Daubail B, Jacquin A, Kazemi A, et al. Subarachnoid hemorrhage revealing Moyamoya syndrome in a patient with may-Hegglin anomaly. Neurologist. 2017;22(5):204–5.CrossRef Bejot Y, Barnay JL, Chavent A, Daubail B, Jacquin A, Kazemi A, et al. Subarachnoid hemorrhage revealing Moyamoya syndrome in a patient with may-Hegglin anomaly. Neurologist. 2017;22(5):204–5.CrossRef
8.
go back to reference Girolami A, Vettore S, Bonamigo E, Fabris F. Thrombotic events in MYH9 gene-related autosomal macrothrombocytopenias (old may-Hegglin, Sebastian, Fechtner and Epstein syndromes). J Thromb Thrombolysis. 2011;32(4):474–7.CrossRef Girolami A, Vettore S, Bonamigo E, Fabris F. Thrombotic events in MYH9 gene-related autosomal macrothrombocytopenias (old may-Hegglin, Sebastian, Fechtner and Epstein syndromes). J Thromb Thrombolysis. 2011;32(4):474–7.CrossRef
9.
go back to reference Bersano A, Guey S, Bedini G, Nava S, Herve D, Vajkoczy P, et al. Research progresses in understanding the pathophysiology of Moyamoya disease. Cerebrovasc Dis. 2016;41(3–4):105–18.CrossRef Bersano A, Guey S, Bedini G, Nava S, Herve D, Vajkoczy P, et al. Research progresses in understanding the pathophysiology of Moyamoya disease. Cerebrovasc Dis. 2016;41(3–4):105–18.CrossRef
10.
go back to reference Jiménez CP. Adult-onset moyamoya disease in a patient with neurofibromatosis type 1. Neurologia. 2016;31:139–41.CrossRef Jiménez CP. Adult-onset moyamoya disease in a patient with neurofibromatosis type 1. Neurologia. 2016;31:139–41.CrossRef
11.
go back to reference Ilyayeva E, Nada K, Farahi Far R, Albright K, Gujral MK, Gold M. Bilateral cerebrovascular stroke as an initial presenting symptom of Moyamoya disease. Case Rep Crit Care. 2018;2018:2591494.PubMedPubMedCentral Ilyayeva E, Nada K, Farahi Far R, Albright K, Gujral MK, Gold M. Bilateral cerebrovascular stroke as an initial presenting symptom of Moyamoya disease. Case Rep Crit Care. 2018;2018:2591494.PubMedPubMedCentral
12.
go back to reference Doctor PN, Choudhari A, Verma M, Merchant RH. Moyamoya syndrome in hemoglobin E-beta thalassemia: a rare presentation and association. J Postgrad Med. 2018;64(4):240–2.CrossRef Doctor PN, Choudhari A, Verma M, Merchant RH. Moyamoya syndrome in hemoglobin E-beta thalassemia: a rare presentation and association. J Postgrad Med. 2018;64(4):240–2.CrossRef
13.
go back to reference Hishikawa T, Sugiu K, Date I. Moyamoya disease: a review of clinical research. Acta Med Okayama. 2016;70(4):229–36.PubMed Hishikawa T, Sugiu K, Date I. Moyamoya disease: a review of clinical research. Acta Med Okayama. 2016;70(4):229–36.PubMed
14.
go back to reference Zuberi AZ, Ahmed BN, Iqbal S, Page S. May-Hegglin anomaly and the devastating consequences of acute cerebral hemispheric infarction. Ann Hematol Oncol. 2016;3(1):1070. Zuberi AZ, Ahmed BN, Iqbal S, Page S. May-Hegglin anomaly and the devastating consequences of acute cerebral hemispheric infarction. Ann Hematol Oncol. 2016;3(1):1070.
15.
go back to reference Balduini CL, Pecci A, Savoia A. Recent advances in the understanding and management of MYH9-related inherited thrombocytopenias. Br J Haematol. 2011;154(2):161–74.CrossRef Balduini CL, Pecci A, Savoia A. Recent advances in the understanding and management of MYH9-related inherited thrombocytopenias. Br J Haematol. 2011;154(2):161–74.CrossRef
16.
go back to reference Fernandez-Prado R, Carriazo-Julio SM, Torra R, Ortiz A, Perez-Gomez MV. MYH9-related disease: it does exist, may be more frequent than you think and requires specific therapy. Clin Kidney J. 2019;12(4):488–93.CrossRef Fernandez-Prado R, Carriazo-Julio SM, Torra R, Ortiz A, Perez-Gomez MV. MYH9-related disease: it does exist, may be more frequent than you think and requires specific therapy. Clin Kidney J. 2019;12(4):488–93.CrossRef
17.
go back to reference Zipfel GJ, Fox DJ Jr, Rivet DJ. Moyamoya disease in adults: the role of cerebral revascularization. Skull Base. 2005;15(1):27–41.CrossRef Zipfel GJ, Fox DJ Jr, Rivet DJ. Moyamoya disease in adults: the role of cerebral revascularization. Skull Base. 2005;15(1):27–41.CrossRef
18.
go back to reference Oki K, Katsumata M, Izawa Y, Takahashi S, Suzuki N, Houkin K, et al. Trends of antiplatelet therapy for the Management of Moyamoya Disease in Japan: results of a Nationwide survey. J Stroke Cerebrovasc Dis. 2018;27(12):3605–12.CrossRef Oki K, Katsumata M, Izawa Y, Takahashi S, Suzuki N, Houkin K, et al. Trends of antiplatelet therapy for the Management of Moyamoya Disease in Japan: results of a Nationwide survey. J Stroke Cerebrovasc Dis. 2018;27(12):3605–12.CrossRef
19.
go back to reference Smith ER, Scott RM. Surgical management of moyamoya syndrome. Skull Base. 2005;15(1):15–26.CrossRef Smith ER, Scott RM. Surgical management of moyamoya syndrome. Skull Base. 2005;15(1):15–26.CrossRef
20.
go back to reference Scott RM, Smith ER. Moyamoya disease and moyamoya syndrome. N Engl J Med. 2009;360(12):1226–37.CrossRef Scott RM, Smith ER. Moyamoya disease and moyamoya syndrome. N Engl J Med. 2009;360(12):1226–37.CrossRef
Metadata
Title
Moyamoya-like vasculopathy associated to MYH9-related thrombocytopenia manifested by multiple cerebral ischemic lesions: a case report
Authors
Athena Cristina Ribigan
Raluca Stefania Badea
Alida Ciocan
Dana Stefan
Bogdan Casaru
Patricia Ioan
Florina Antochi
Ovidiu Băjenaru
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Neurology / Issue 1/2020
Electronic ISSN: 1471-2377
DOI
https://doi.org/10.1186/s12883-020-01927-6

Other articles of this Issue 1/2020

BMC Neurology 1/2020 Go to the issue